BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18646207)

  • 1. Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genes.
    Richard M; Arfi A; Rhinn H; Gandolphe C; Scherman D
    J Neurosci Res; 2008 Nov; 86(15):3285-94. PubMed ID: 18646207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment.
    Arfi A; Richard M; Gandolphe C; Bonnefont-Rousselot D; Thérond P; Scherman D
    Mol Genet Metab; 2011 May; 103(1):18-25. PubMed ID: 21353610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
    Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
    Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII.
    Fyfe JC; Kurzhals RL; Lassaline ME; Henthorn PS; Alur PR; Wang P; Wolfe JH; Giger U; Haskins ME; Patterson DF; Sun H; Jain S; Yuhki N
    Genomics; 1999 Jun; 58(2):121-8. PubMed ID: 10366443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y
    J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models.
    Simonaro CM; D'Angelo M; Haskins ME; Schuchman EH
    Pediatr Res; 2005 May; 57(5 Pt 1):701-7. PubMed ID: 15746260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease.
    Walton RM; Wolfe JH
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):760-9. PubMed ID: 17882020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease.
    Shen JS; Meng XL; Maeda H; Ohashi T; Eto Y
    J Gene Med; 2004 Nov; 6(11):1206-15. PubMed ID: 15459963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration.
    Boche D; Cunningham C; Docagne F; Scott H; Perry VH
    Neurobiol Dis; 2006 Jun; 22(3):638-50. PubMed ID: 16510291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible.
    Heuer GG; Passini MA; Jiang K; Parente MK; Lee VM; Trojanowski JQ; Wolfe JH
    Ann Neurol; 2002 Dec; 52(6):762-70. PubMed ID: 12447930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
    Karolewski BA; Wolfe JH
    Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
    Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
    Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez M; Dieter T; Holden CC; Sukegawa K; Orii T; Kondo N; Sly WS
    Hum Mol Genet; 2003 May; 12(9):961-73. PubMed ID: 12700165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.
    Villani GR; Gargiulo N; Faraonio R; Castaldo S; Gonzalez Y Reyero E; Di Natale P
    J Neurosci Res; 2007 Feb; 85(3):612-22. PubMed ID: 17139681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration.
    Rudelius M; Osanger A; Kohlmann S; Augustin M; Piontek G; Heinzmann U; Jennen G; Russ A; Matiasek K; Stumm G; Schlegel J
    Acta Neuropathol; 2006 Sep; 112(3):267-76. PubMed ID: 16791600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis in longest known survivor of mucopolysaccharidosis type VII.
    Storch S; Wittenstein B; Islam R; Ullrich K; Sly WS; Braulke T
    Hum Genet; 2003 Feb; 112(2):190-4. PubMed ID: 12522561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis.
    Brudzewsky D; Pedersen AE; Claesson MH; Gad M; Kristensen NN; Lage K; Jensen T; Tommerup N; Larsen LA; Knudsen S; Tümer Z
    Scand J Immunol; 2009 May; 69(5):437-46. PubMed ID: 19508375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40.
    Takahashi N; de Jager VC; Glück A; Letzkus M; Hartmann N; Staedtler F; Ribeiro-Dias F; Heuvelmans-Jacobs M; van den Berg WB; Joosten LA
    Arthritis Rheum; 2008 Nov; 58(11):3471-84. PubMed ID: 18975327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.